Inhibition of ITGB1 significantly reduced cancer cell aggressiveness, indicating that ITGB1 and ITGB1-mediated cancer signalling may be promising therapeutic targets for HNSCC. The gene discussed is ITGB1; the disease is head and neck squamous cell carcinoma.